Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis
Journal Article
·
· Journal of Medicinal Chemistry
- Merck
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- INDUSTRY
- OSTI ID:
- 1251230
- Journal Information:
- Journal of Medicinal Chemistry, Vol. 58, Issue (19) ; 10, 2015; ISSN 0022-2623
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Identification and Optimization of PDE10A Inhibitors Using Fragment-Based Screening by Nanocalorimetry and X-ray Crystallography
Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of [ beta]-Secretase (BACE1) through Fragment-Based Drug Design
Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
Journal Article
·
Thu Jul 07 00:00:00 EDT 2016
· J. Biomol. Screen.
·
OSTI ID:1251230
+5 more
Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of [ beta]-Secretase (BACE1) through Fragment-Based Drug Design
Journal Article
·
Wed May 29 00:00:00 EDT 2013
· J. Med. Chem.
·
OSTI ID:1251230
+15 more
Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
Journal Article
·
Tue Dec 11 00:00:00 EST 2012
· Journal of Medicinal Chemistry
·
OSTI ID:1251230
+13 more